CD80/B7-1 Mouse Monoclonal Antibody [8-E5]
cat.: M1007-10
Product Type: Mouse monoclonal IgG2b, primary antibodies
Species reactivity: Human, Mouse
Applications: WB, IF-Cell, IHC-P, FC
Clonality: Monoclonal
Clone number: 8-E5
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
Storage buffer: 1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 2ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 33 kDa
Isotype: IgG2b
Immunogen: Synthetic peptide within human CD80 aa 74-118 / 288.
Positive control: Human brain tissue lysates, human brain tissue, SH-SY5Y, Hela.
Subcellular location: Membrane.
Recommended Dilutions:
  WB
  IF-Cell
  IHC-P

1:1,000
1:100-1:200
1:50
Uniprot #: SwissProt: P33681 Human | Q00609 Mouse
Alternative names: Activation B7-1 antigen B lymphocyte activation antigen B7 B7 B7-1 B7-1 antigen B7.1 BB1 CD28 antigen ligand 1 CD28LG CD28LG1 CD80 CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) CD80 antigen CD80 molecule CD80_HUMAN Costimulatory factor CD80 costimulatory molecule variant IgV-CD80 CTLA-4 counter-receptor B7.1 LAB7 T-lymphocyte activation antigen CD80
Images
M1007-10_1.jpg Fig1: Western blot analysis of CD80/B7-1 on human brain tissue lysates with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/1,000 dilution.

Lysates/proteins at 40 µg/Lane.

Predicted band size: 33 kDa
Observed band size: 60 kDa

Exposure time: 3 minutes 10 seconds;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (M1007-10) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature.
M1007-10_2.jpg Fig2: Immunohistochemical analysis of paraffin- embedded human brain tissue using using anti-CD80 Mouse mAb (Cat. # M1007-10).
M1007-10_3.png Fig3: Immunocytochemistry analysis of SH-SY5Y cells labeling CD80/B7-1 with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
M1007-10_4.png Fig4: Immunocytochemistry analysis of Hela cells labeling CD80/B7-1 with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-CD80/B7-1 antibody (M1007-10) at 1/100 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.